Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Infectious Mononucleosis × valomaciclovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Infectious Mononucleosis 1 Epstein-Barr Virus Infections 1

Interventions

Matrix-M 2 valomaciclovir 1 Valacyclovir 1 Rituximab 1 Procalcitonin 1 Brentuximab Vedotin 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00575185 2017-03-22

Mono6

University of Minnesota

Phase 1/2 Completed

23 enrolled 8 charts

Infectious Mononucleosis, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡